المؤلفون: Skalova A., Ptakova N., Santana T., Agaimy A., Ihrler S., Uro-Coste E., Thompson L. D. R., Bishop J. A., Baneckova M., Rupp N. J., Morbini P., De Sanctis S., Schiavo-Lena M., Vanecek T., Michal M., Leivo I.

المساهمون: Skalova, A., Ptakova, N., Santana, T., Agaimy, A., Ihrler, S., Uro-Coste, E., Thompson, L. D. R., Bishop, J. A., Baneckova, M., Rupp, N. J., Morbini, P., De Sanctis, S., Schiavo-Lena, M., Vanecek, T., Michal, M., Leivo, I.

مصطلحات موضوعية: apocrine, cohort studie, gene fusion, intercalated duct carcinoma, intraductal carcinoma, NCOA4-RET, RET-targeted therapy, salivary gland neoplasm, TRIM27-RET, Adolescent, Adult, Aged, 80 and over, Biomarkers, Tumor, Carcinoma, Intraductal, Noninfiltrating, DNA-Binding Protein, Female, Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing, Human, In Situ Hybridization, Fluorescence, Lymphatic Metastasi, Male, Middle Aged, Neoplasm Invasivene, Nuclear Protein

Relation: info:eu-repo/semantics/altIdentifier/pmid/31162284; info:eu-repo/semantics/altIdentifier/wos/WOS:000487648600002; volume:43; issue:10; firstpage:1303; lastpage:1313; numberofpages:11; journal:THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY; http://hdl.handle.net/11571/1438097; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85066779841

الاتاحة: http://hdl.handle.net/11571/1438097
https://doi.org/10.1097/PAS.0000000000001301

المؤلفون: Agnese Barnabei, Salvatore Maria Corsello, Francesco Torino, Rosa Maria Paragliola

المصدر: Current molecular medicine. 10(7)

مصطلحات موضوعية: vandetanib, endocrine system diseases, Settore MED/06 - Oncologia Medica, sunitinib, medicine.medical_treatment, Context (language use), Antineoplastic Agents, Multiple Endocrine Neoplasia Type 2a, Biochemistry, Targeted therapy, Mice, Neoplastic Syndromes, Hereditary, medullary thyroid carcinoma, medicine, Animals, Humans, Neoplastic transformation, Molecular Targeted Therapy, Thyroid Neoplasms, Molecular Biology, Protein Kinase Inhibitors, Tyrosine kinase inhibitors, business.industry, Carcinoma, Multiple Endocrine Neoplasia, Proto-Oncogene Proteins c-ret, Medullary thyroid cancer, General Medicine, Protein-Tyrosine Kinases, targeted therapy, medicine.disease, Tyrosine kinase inhibitors, medullary thyroid carcinoma, multiple endocrine neoplasia, RET, targeted therapy, vandetanib, sunitinib, sorafenib, Carcinoma, Neuroendocrine, Clinical trial, Medullary carcinoma, Carcinoma, Medullary, Immunology, Cancer research, Molecular Medicine, sorafenib, RET, business, Tyrosine kinase, Signal Transduction

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9847663ec916ed146953f5fa078b2c7
https://pubmed.ncbi.nlm.nih.gov/20712590